Expression of Cytokeratin 5/6 in Epithelial Neoplasms: An Immunohistochemical Study of 509 Cases
Top Cited Papers
- 1 January 2002
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 15 (1), 6-10
- https://doi.org/10.1038/modpathol.3880483
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Anti‐mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasmsHistopathology, 2000
- Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the PleuraLaboratory Investigation, 2000
- Value of Cytokeratin 5/6 Immunostaining in Distinguishing Epithelial Mesothelioma of the Pleura From Lung AdenocarcinomaThe American Journal of Surgical Pathology, 1998
- E‐cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinomaHistopathology, 1998
- Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinomaHuman Pathology, 1998
- The Immunohistochemical Diagnostic Panel for Epithelial MesotheliomaThe American Journal of Surgical Pathology, 1997
- The Value of Antibodies 44-3A6, SM3, HBME-1, and Thrombomodulin in Differentiating Epithelial Pleural Mesothelioma From Lung AdenocarcinomaThe American Journal of Surgical Pathology, 1997
- Calretinin: A Novel Immunocytochemical Marker for MesotheliomaThe American Journal of Surgical Pathology, 1996
- Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomasVirchows Archiv B Cell Pathology Including Molecular Pathology, 1989
- Epidemiology of mesothelioma from estimated incidencePreventive Medicine, 1977